通过X (以前的Twitter) 对药品单个交易的分销调查
Ruoyu Zhang1, Naoko Yoshida1,2,3
1Clinical Pharmacy and Healthcare Sciences, Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.
Biological & pharmaceutical bulletin
|July 21, 2025
概括
像X这样的社交媒体平台被用来非法销售药品,特别是精神药物. 调查显示,这些交易构成公共卫生风险,需要持续监测.
科学领域:
- 制药科学 制药科学
- 社交媒体分析 社交媒体分析
- 公共卫生 公共卫生
背景情况:
- 在社交网络网站上对药品的个人交易是不合适的分销道.
- 这些交易可能代表企业对消费者的伪装销售,构成公共卫生风险.
研究的目的:
- 调查日本主要社交网站X (原名Twitter) 上的个人药品交易的状态.
- 确定与这些在线药品销售相关的模式和风险.
主要方法:
- 来自假冒和非法药物信息中心的1389个疑似药品交易帖子的文本挖掘.
- 分析与心理药物交易相关的特定日本标签 (#Okusuri mogumogu).
- 购买和随后分析 (视觉,制造商认证,拉曼散射,HPLC) 通过X.获得的药物.
主要成果:
- 标签#Okusuri mogumogu经常与涉及精神药物的交易有关.
- 购买的产品包括未经要求的精神药物和非药品.
- 分析表明,获得的药品不太可能被伪造,尽管分销方法不合适.
结论:
- 像X这样的社交媒体平台上的个人药品交易是一个重大的公共卫生问题.
- 持续监测至关重要,以减轻不适当的药品分销和使用对健康的危害.
更多相关视频
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
8.5K
08:54Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
7.8K
相关概念视频
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
01:25Drug Distribution: Volume of Distribution
6.0K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
6.0K
01:20Volume of Distribution
468
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
468
01:02Prescription, Nonprescription and Orphan Drugs
849
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
849
01:11Drug Distribution: Overview
303
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
303
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K